BELKIN Vision

Alcon recently completed the acquisition of BELKIN Vision. The acquisition includes BELKIN Vision's Direct Selective Laser Trabeculoplasty (DSLT) technology. This broadens Alcon’s existing glaucoma portfolio of pharmaceutical drops (currently available in the U.S. only) and implantables, with a first-line laser treatment option. In partnership with our new associates, Alcon plans to accelerate the expansion of first-line DSLT use globally. Learn more: https://lnkd.in/gPJ29AHA

DSLT is transforming the patient experience. Here are some highlights captured in Scotland at Ayrshire Eye Clinic where we met newly diagnosed glaucoma patients who experienced DSLT for the first time. #DSLT #glaucoma #innovation #ophthalmology Sathish Srinivasan

Watch this fascinating discussion between Dr. Paul Singh and Dr. Nate Radcliffe at AAO in San Francisco as they discuss the first-line therapy that that they think most doctors would choose for themselves. ( 📣 Spoiler Alert: It's laser therapy) The full recording and more talks like these are available via our YouTube channel: https://lnkd.in/e_zkHPdf #dslt #innovation #ophthalmology

🎥 Relive our Highlights from EGS in Dublin! 🌟 From insightful presentations at our symposium to engaging discussions on our booth, we're delighted to share a video montage capturing the best moments from the event. Thank you again to all of our symposium speakers and to everyone who helped make this event a tremendous success. Carlo Enrico Traverso Lai-Yeung Ngai Beatriz Puerto #EGS2024 #glaucoma #innovation #medicaldevice #DSLT

How do you talk to your patients about laser as a first-line therapy for glaucoma? In the clip below, Dr. Paul Singh shares how he talks about laser therapy with his patients. Want to hear more? Watch the full discussion here-> https://lnkd.in/gGn8wrPq #ascrsofficial #innovation #ophthalmology #DSLT #glaucoma Inder Singh

📢 We'll be in Prague this weekend for #AECOS 2024! Very much looking forward to hearing from ophthalmology's thought leaders and to sharing updates on DSLT. Precision. Automation. Efficiency. #DSLT #ophthalmology #glaucoma #AECOS #AECOSPrague

🌟 Thank you for joining us at EGS 2024 in Dublin! 🌟 We were thrilled to see so many of you at our booth and appreciate the engaging conversations and connections made. A special thank you to Carlo Enrico Traverso, Lai Ngai, Michele Lanza, and Beatriz Puerto Hernandez who shared their invaluable insights during our symposium. We look forward to continuing the conversation about DSLT and the BELKIN Vision Eagle at the next one! #EGS2024 #glaucoma #innovation #medicaldevice #dslt

Save your spot! Hear from leading experts at our lunchtime symposium tomorrow with Prof. Carlo Enrico Traverso, Dr. Lai-Yeung Ngai, Dr. Michele Lanza, and Dra. Beatriz Puerto Hernandez as they share their practical insights with DSLT and discuss how the treatment can help boost efficiency and reduce waiting times in your practice. Don’t miss out – register now! 👉 https://lnkd.in/d7z4hps9 Want to learn more? Drop by booth #23 to discover the Eagle device. #towardsegs2024 #egs #Glaucoma #DSLT #Ophthalmology #MedicalInnovation #HealthcareEfficiency

The EGS European Glaucoma Society Congress is almost here! Join us at Booth 23 to discover DSLT and experience the Eagle device. 🔔 Don't miss our lunchtime symposium! Join esteemed experts Prof. Carlo Enrico Traverso, Dr. Lai-Yeung Ngai, Dr. Michele Lanza, and Dra. Beatriz Puerto Hernandez on June 1st for our lunchtime symposium where they will share their real-world experience with DSLT and discuss how to enhance efficiency and reduce waiting lists in your practice. (Room Wicklow Hall 2b | 13:00) Secure your spot: https://lnkd.in/d7z4hps9 #towardsegs2024 #EGS #Glaucoma #DSLT #Ophthalmology #MedicalInnovation #HealthcareEfficiency

Recently at ASCRS in Boston we had Nate Radcliffe, Paul Singh, and Sahar Bedrood discuss the impact that DSLT will have on treating glaucoma with laser closer to the point of diagnosis. For more information about the LiGHT trial referenced, read the paper here: https://lnkd.in/eVPq4qnj #ascrsofficial #innovation #ophthalmology #DSLT #glaucoma